What's happening
This bill creates a Clinical Trial Access and Education Fund to help patients access and learn about clinical trials, covering related costs.
Why it matters
Helps reduce financial barriers for patients. By covering ancillary costs such as travel, lodging, and assistance for those unable to travel alone, the fund aims to make clinical trials more accessible to people who otherwise couldn’t afford participation.
Targets patients with serious health needs. The fund specifically supports those with life-threatening or disabling conditions, potentially expanding treatment options for vulnerable populations who may benefit most from access to cutting-edge therapies.
Focuses on outreach and education. Grants can be used for patient outreach, education, and navigation services, helping patients and their families understand clinical trials and how to join them, which could increase participation and diversity in trials.
Prioritizes equity and oversight. Reimbursement is based on financial need (up to 700% of the federal poverty level), and programs must have institutional review board approval and comply with legal standards, aiming to ensure fairness, compliance, and ethical conduct.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Who cares
- Likely support
Patients with life-threatening or disabling conditions
The bill would support clinical trial transportation, lodging, education and enrollment assistance, including needs-based reimbursement of reasonable ancillary costs for participants with incomes at or below 700% of the federal poverty level.
Medical schools, hospitals and patient nonprofits
Eligible organizations could compete for grants, subject to appropriations, to help patients access clinical trials and would have to report annually on spending and access efforts.
New York State Department of Health
The department would administer the fund, establish the grant application process and issue implementing regulations.
Clinical trial sponsors and institutional review boards
Grantees would collaborate with sponsors and providers to notify prospective participants about available assistance, and trial-associated review boards would have to approve reimbursement programs.
Headline styles
Help Patients Join Trials
Plain English, a few words. Used as the page title.
Sponsors
15 Co-sponsors
1 Multi-sponsor
History
- Print number 180a
- Amend and recommit to ways and means
- Referred to ways and means
- Reported referred to ways and means
- Referred to health
Companion bill
The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.
Help Patients Join Trials
In Senate Committee · Finance · Sponsor Gustavo Rivera
Full text
3 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
180--A
2021-2022 Regular Sessions
IN ASSEMBLY (Prefiled)
January 6, 2021
Introduced by M. of A. GOTTFRIED, PAULIN, GUNTHER, L. ROSENTHAL, CAHILL, GALEF, ENGLEBRIGHT, ZEBROWSKI, LUPARDO, ABINANTI, WEPRIN, SAYEGH, SALKA, SEAWRIGHT -- Multi-Sponsored by -- M. of A. CARROLL -- read once and referred to the Committee on Health -- reported and referred to the Committee on Ways and Means -- recommitted to the Committee on Ways and Means in accordance with Assembly Rule 3, sec. 2 -- committee discharged, bill amended, ordered reprinted as amended and recommitted to said committee
AN ACT to amend the public health law, in relation to establishing the clinical trial access and education fund
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. The public health law is amended by adding a new section 2424 to read as follows:
§ 2424. Clinical trial access and education fund. 1. Definitions. For the purposes of this section, the following terms shall have the following meanings:
a. "Eligible applicant" means (i) a medical school that sponsors a clinical trial, (ii) a not-for-profit organization with experience and expertise working with patients with life-threatening or disabling conditions or diseases, (iii) a health care provider organization, association or society, (iv) a general hospital defined in article twentyeight of this chapter, (v) a county or city health department, or (vi) a municipality.
b. "Clinical trial" shall have the same meaning as in subdivision two-b of section forty-nine hundred of this chapter.
c. "Ancillary costs" means costs associated with participation in a clinical trial, including but not limited to costs for:
(i) travel;
(ii) lodging;
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD00038-02-2
(iii) parking and tolls;
(iv) a travel companion to assist patients who are elderly, very young, or too ill to travel alone; and
(v) other costs considered appropriate jointly by the department, the service providing organization and the trial site.
2. Establishment of fund. There is hereby established within the department a clinical trial access and education fund. Subject to appropriations, the department shall provide grants to eligible applicants on a competitive request for proposal basis to provide one or more of the following services to patients with life-threatening or disabling conditions or diseases, as such terms are defined in section forty-nine hundred of this chapter, to facilitate access to or education on clinical trials of treatments for the patient's condition or disease:
a. transportation services and lodging to provide patients with access to clinical trials or other related treatments while enrolled in a clinical trial or to access testing and other services to determine patient eligibility for a clinical trial;
b. patient outreach and education services to educate patients, their families and health care providers about the existence of and how patients may enroll in clinical trials, under section two hundred seven of this chapter; and
c. patient navigation services to help patients to determine if they are eligible for clinical trials, to help patients to enroll in clinical trials and to assist patients in dealing with insurance or other issues which serve as barriers to patient enrollment in clinical trials.
3. Applications. a. The commissioner shall establish an application process by which eligible applicants may apply for a grant under this section. The application shall include:
(i) the geographic area in which the services shall be provided;
(ii) a detailed description of the services to be provided;
(iii) applicant's experience working with patients with life-threatening or disabling conditions or diseases;
(iv) applicant's ability to provide patient outreach or clinical trial education and navigation services, or coordinate or provide transportation and lodging for patients; and
(v) any other information that the commissioner deems relevant and appropriate.
b. Eligible applicants shall:
(i) have experience and expertise working with patients with lifethreatening or disabling conditions or diseases;
(ii) provide patient outreach, education and health care navigation services;
(iii) collaborate with physicians, health care providers, and clinical trial sponsors to notify a prospective subject about the program when:
(1) the prospective subject consents to a clinical trial; and
(2) funding is available to provide the program for the clinical trial in which the prospective subject participates; and
(iv) reimburse subjects based on financial need to subjects whose income is at or below seven hundred percent of the federal poverty level, which shall include reimbursement for reasonable ancillary costs.
4. Institutional review board requirements. A reimbursement program under this section shall:
a. be approved by the institutional review board associated with the clinical trial; and
b. comply with applicable federal and state laws.
5. Reimbursement. Reimbursement to a subject of ancillary costs under the program:
a. does not constitute an undue inducement to participate in a clinical trial;
b. is not considered coercion or the exertion of undue influence to participate in a clinical trial; and
c. is meant to accomplish parity in access to clinical trials and remove barriers to participation in clinical trials for financially burdened subjects.
6. Reports. Grantees shall file an annual report with the commissioner, in such form and with such information and data as the commissioner prescribes detailing the expenditure of grant funds and summarizing the efforts undertaken to increase patient access to clinical trials.
7. Regulations. The commissioner shall make regulations reasonably necessary to implement the provisions of this section.
§ 2. This act shall take effect immediately.
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.